(Q84315469)

12 December 2020

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement

1 reference

12 December 2020

Cyclosporin A inhibits the replication of diverse coronaviruses

1 reference

12 December 2020

Inhibition of novel β coronavirus replication by a combination of interferon-α2b and ribavirin

1 reference

12 December 2020

MERS-coronavirus replication induces severe in vitro cytopathology and is strongly inhibited by cyclosporin A or interferon-α treatment

1 reference

12 December 2020

Family cluster of Middle East respiratory syndrome coronavirus infections

1 reference

12 December 2020

Hospital outbreak of Middle East respiratory syndrome coronavirus

1 reference

12 December 2020

Transmission scenarios for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) and how to tell them apart

1 reference

12 December 2020

Novel coronavirus infections in Jordan, April 2012: epidemiological findings from a retrospective investigation

1 reference

12 December 2020

A family cluster of Middle East Respiratory Syndrome Coronavirus infections related to a likely unrecognized asymptomatic or mild case

1 reference

12 December 2020

Therapeutic options for Middle East respiratory syndrome coronavirus (MERS-CoV)--possible lessons from a systematic review of SARS-CoV therapy

1 reference

12 December 2020

Treatment with interferon-α2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques

1 reference

12 December 2020

Middle East respiratory syndrome coronavirus infection mediated by the transmembrane serine protease TMPRSS2.

1 reference

12 December 2020

Broad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirus

1 reference

12 December 2020

Middle East respiratory syndrome coronavirus: quantification of the extent of the epidemic, surveillance biases, and transmissibility

1 reference

12 December 2020

Interferon-β and mycophenolic acid are potent inhibitors of Middle East respiratory syndrome coronavirus in cell-based assays

1 reference

12 December 2020

Ribavirin and interferon therapy in patients infected with the Middle East respiratory syndrome coronavirus: an observational study

1 reference

12 December 2020

Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor

1 reference

12 December 2020

Community case clusters of Middle East respiratory syndrome coronavirus in Hafr Al-Batin, Kingdom of Saudi Arabia: a descriptive genomic study

1 reference

12 December 2020

Hospital-associated outbreak of Middle East respiratory syndrome coronavirus: a serologic, epidemiologic, and clinical description

1 reference

12 December 2020

Ribavirin and interferon-α2b as primary and preventive treatment for Middle East respiratory syndrome coronavirus: a preliminary report of two cases

1 reference

12 December 2020

Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture

1 reference

12 December 2020

Repurposing of clinically developed drugs for treatment of Middle East respiratory syndrome coronavirus infection

1 reference

12 December 2020

Targeting membrane-bound viral RNA synthesis reveals potent inhibition of diverse coronaviruses including the middle East respiratory syndrome virus

1 reference

12 December 2020

Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study.

1 reference

12 December 2020

Virological and serological analysis of a recent Middle East respiratory syndrome coronavirus infection case on a triple combination antiviral regimen

1 reference

12 December 2020

Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: a single-center experience in Saudi Arabia

1 reference

12 December 2020

An observational, laboratory-based study of outbreaks of middle East respiratory syndrome coronavirus in Jeddah and Riyadh, kingdom of Saudi Arabia, 2014.

1 reference

12 December 2020

2014 MERS-CoV outbreak in Jeddah--a link to health care facilities

1 reference

12 December 2020

Middle Eastern Respiratory Syndrome Corona Virus (MERS CoV): case reports from a tertiary care hospital in Saudi Arabia

1 reference

12 December 2020

IFN-α2a or IFN-β1a in combination with ribavirin to treat Middle East respiratory syndrome coronavirus pneumonia: a retrospective study

1 reference

12 December 2020

Protective Effect of Intranasal Regimens Containing Peptidic Middle East Respiratory Syndrome Coronavirus Fusion Inhibitor Against MERS-CoV Infection

1 reference

12 December 2020

Treatment With Lopinavir/Ritonavir or Interferon-β1b Improves Outcome of MERS-CoV Infection in a Nonhuman Primate Model of Common Marmoset

1 reference

12 December 2020

Middle East respiratory syndrome coronavirus (MERS-CoV): A cluster analysis with implications for global management of suspected cases

1 reference

12 December 2020

Transmission characteristics of MERS and SARS in the healthcare setting: a comparative study

1 reference

12 December 2020

A humanized neutralizing antibody against MERS-CoV targeting the receptor-binding domain of the spike protein.

1 reference

12 December 2020

Molecular Epidemiology of Hospital Outbreak of Middle East Respiratory Syndrome, Riyadh, Saudi Arabia, 2014.

1 reference

12 December 2020

Combination therapy with lopinavir/ritonavir, ribavirin and interferon-α for Middle East respiratory syndrome

1 reference

12 December 2020

Multifacility Outbreak of Middle East Respiratory Syndrome in Taif, Saudi Arabia

1 reference

12 December 2020

Acute Management and Long-Term Survival Among Subjects With Severe Middle East Respiratory Syndrome Coronavirus Pneumonia and ARDS.

1 reference

12 December 2020

3B11-N, a monoclonal antibody against MERS-CoV, reduces lung pathology in rhesus monkeys following intratracheal inoculation of MERS-CoV Jordan-n3/2012

1 reference

12 December 2020

Drivers of MERS-CoV transmission: what do we know?

1 reference

12 December 2020

Human polyclonal immunoglobulin G from transchromosomic bovines inhibits MERS-CoV in vivo

1 reference

12 December 2020

Middle East Respiratory Syndrome Coronavirus during Pregnancy, Abu Dhabi, United Arab Emirates, 2013.

1 reference

12 December 2020

Notes from the Field: Nosocomial Outbreak of Middle East Respiratory Syndrome in a Large Tertiary Care Hospital--Riyadh, Saudi Arabia, 2015.

1 reference

12 December 2020

A novel peptide with potent and broad-spectrum antiviral activities against multiple respiratory viruses.

1 reference

12 December 2020

Glycopeptide Antibiotics Potently Inhibit Cathepsin L in the Late Endosome/Lysosome and Block the Entry of Ebola Virus, Middle East Respiratory Syndrome Coronavirus (MERS-CoV), and Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV).

1 reference

12 December 2020

Transmission of Middle East Respiratory Syndrome Coronavirus Infections in Healthcare Settings, Abu Dhabi

1 reference

12 December 2020

Nitazoxanide, a new drug candidate for the treatment of Middle East respiratory syndrome coronavirus

1 reference

12 December 2020

Treatment outcomes for patients with Middle Eastern Respiratory Syndrome Coronavirus (MERS CoV) infection at a coronavirus referral center in the Kingdom of Saudi Arabia

1 reference

12 December 2020

Presentation and outcome of Middle East respiratory syndrome in Saudi intensive care unit patients

1 reference

12 December 2020

Patient characteristics infected with Middle East respiratory syndrome coronavirus infection in a tertiary hospital

1 reference

12 December 2020

Single-dose treatment with a humanized neutralizing antibody affords full protection of a human transgenic mouse model from lethal Middle East respiratory syndrome (MERS)-coronavirus infection

1 reference

12 December 2020

Description of a Hospital Outbreak of Middle East Respiratory Syndrome in a Large Tertiary Care Hospital in Saudi Arabia.

1 reference

12 December 2020

Abelson Kinase Inhibitors Are Potent Inhibitors of Severe Acute Respiratory Syndrome Coronavirus and Middle East Respiratory Syndrome Coronavirus Fusion

1 reference

12 December 2020

Increase in Middle East Respiratory Syndrome-Coronavirus Cases in Saudi Arabia Linked to Hospital Outbreak With Continued Circulation of Recombinant Virus, July 1-August 31, 2015.

1 reference

12 December 2020

An outbreak of Middle East Respiratory Syndrome (MERS) due to coronavirus in Al-Ahssa Region, Saudi Arabia, 2015.

1 reference

12 December 2020

A recombinant receptor-binding domain of MERS-CoV in trimeric form protects human dipeptidyl peptidase 4 (hDPP4) transgenic mice from MERS-CoV infection

1 reference

12 December 2020

Update on therapeutic options for Middle East Respiratory Syndrome Coronavirus (MERS-CoV).

1 reference

12 December 2020

Effective inhibition of MERS-CoV infection by resveratrol

1 reference

12 December 2020

Outbreak of Middle East Respiratory Syndrome-Coronavirus Causes High Fatality After Cardiac Operations

1 reference

12 December 2020

Inactivation of Middle East respiratory syndrome-coronavirus in human plasma using amotosalen and ultraviolet A light

1 reference

12 December 2020

Safety and tolerability of a novel, polyclonal human anti-MERS coronavirus antibody produced from transchromosomic cattle: a phase 1 randomised, double-blind, single-dose-escalation study

1 reference

12 December 2020

Treatment of Middle East Respiratory Syndrome with a combination of lopinavir-ritonavir and interferon-β1b (MIRACLE trial): study protocol for a randomized controlled trial

1 reference

12 December 2020

Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease.

1 reference

12 December 2020

MERS-CoV pathogenesis and antiviral efficacy of licensed drugs in human monocyte-derived antigen-presenting cells.

1 reference

12 December 2020

Saracatinib Inhibits Middle East Respiratory Syndrome-Coronavirus Replication In Vitro.

1 reference

12 December 2020

Healthcare-associated infections: the hallmark of Middle East respiratory syndrome coronavirus with review of the literature

1 reference

12 December 2020

A Novel Nanobody Targeting Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Receptor-Binding Domain Has Potent Cross-Neutralizing Activity and Protective Efficacy against MERS-CoV

1 reference

12 December 2020